Recent clinical and pharmacological advancements of incretin-based therapy and the effects of incretin on physiology
A novel therapeutic target for diabetes mellitus is incretin-based therapies, glucagon-like peptide-1, and glucose-dependent insulinotropic polypeptides are released from the gastrointestinal (GI) tract and act on beta cells of pancreatic islets by increasing the secretion of insulin. The management...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2024-01-01
|
| Series: | Journal of Diabetology |
| Subjects: | |
| Online Access: | https://journals.lww.com/jodb/fulltext/2024/15010/recent_clinical_and_pharmacological_advancements.5.aspx |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|